Literature DB >> 30414705

High prevalence of chronic kidney disease in patients with multiple endocrine neoplasia type 1 and improved kidney function after parathyroidectomy.

Patience Green1, Jonathan Zagzag2, Dhaval Patel1, Lee S Weinstein3, William F Simonds3, Jenny Blau3, Stephen Marx3, Electron Kebebew1, Nancy Perrier2, Naris Nilubol4.   

Abstract

BACKGROUND: Because chronic kidney disease is an important comorbidity associated with primary hyperparathyroidism, we sought to evaluate the prevalence of chronic kidney disease and effects of parathyroidectomy on kidney function in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism.
METHODS: We performed a retrospective analysis of 112 patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism who had at least 1 operation for primary hyperparathyroidism at 2 tertiary referral centers. The preoperative and postoperative estimated glomerular filtration rates were compared. The prevalence of chronic kidney disease stage 3 or worse (estimated glomerular filtration rates less than 60 mL/min/1.73m2) in this cohort was compared to the rates in the US population reported by the Centers for Disease Control and Prevention.
RESULTS: The median age at the time of parathyroidectomy was 36.5 years (range: 12-76 years). A total of 99 patients had biochemical remission. The rate of chronic kidney disease stage 3 or worse in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism was greater than that observed in the US population for ages 20-39 and 40-59 (5% [n = 2/44] vs 0.39% [n = 18/4565], P = .015 and 10% [n = 4/40] vs 2.31% (n = 89/3848), P = .015, respectively). We observed improved estimated glomerular filtration rates in those with chronic kidney disease stage 3 or worse postoperatively (48 vs 57 mL/min/1.73m2, P = .047). A successful parathyroidectomy normalized all 24-hour urine calcium excretion.
CONCLUSION: An indication for early parathyroidectomy should include estimated glomerular filtration rates less than 60mL/min/1.73m2 in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30414705      PMCID: PMC8191379          DOI: 10.1016/j.surg.2018.04.064

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  24 in total

1.  The anatomic basis of parathyroid surgery.

Authors:  C Wang
Journal:  Ann Surg       Date:  1976-03       Impact factor: 12.969

Review 2.  PPIs and kidney disease: from AIN to CKD.

Authors:  Dennis G Moledina; Mark A Perazella
Journal:  J Nephrol       Date:  2016-04-12       Impact factor: 3.902

3.  Incidence and prevalence of primary hyperparathyroidism in a racially mixed population.

Authors:  Michael W Yeh; Philip H G Ituarte; Hui Cynthia Zhou; Stacie Nishimoto; In-Lu Amy Liu; Avital Harari; Philip I Haigh; Annette L Adams
Journal:  J Clin Endocrinol Metab       Date:  2013-02-15       Impact factor: 5.958

4.  Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Authors:  Andrew S Levey; Josef Coresh; Tom Greene; Lesley A Stevens; Yaping Lucy Zhang; Stephen Hendriksen; John W Kusek; Frederick Van Lente
Journal:  Ann Intern Med       Date:  2006-08-15       Impact factor: 25.391

5.  Predictors of renal function in primary hyperparathyroidism.

Authors:  Marcella D Walker; Thomas Nickolas; Anna Kepley; James A Lee; Chiyuan Zhang; Donald J McMahon; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2014-02-14       Impact factor: 5.958

6.  Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial.

Authors:  Jens Bollerslev; Svante Jansson; Charlotte L Mollerup; Jörgen Nordenström; Eva Lundgren; Ove Tørring; Jan-Erik Varhaug; Marek Baranowski; Sylvi Aanderud; Celina Franco; Bo Freyschuss; Gunhild A Isaksen; Thor Ueland; Thord Rosen
Journal:  J Clin Endocrinol Metab       Date:  2007-02-06       Impact factor: 5.958

7.  Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial.

Authors:  Elena Ambrogini; Filomena Cetani; Luisella Cianferotti; Edda Vignali; Chiara Banti; Giuseppe Viccica; Annalisa Oppo; Paolo Miccoli; Piero Berti; John P Bilezikian; Aldo Pinchera; Claudio Marcocci
Journal:  J Clin Endocrinol Metab       Date:  2007-05-29       Impact factor: 5.958

8.  Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity.

Authors:  Cristina Eller-Vainicher; Iacopo Chiodini; Claudia Battista; Raffaella Viti; Maria Lucia Mascia; Sara Massironi; Maddalena Peracchi; Leonardo D'Agruma; Salvatore Minisola; Sabrina Corbetta; David E C Cole; Anna Spada; Alfredo Scillitani
Journal:  J Bone Miner Res       Date:  2009-08       Impact factor: 6.741

Review 9.  Chronic kidney disease: effects on the cardiovascular system.

Authors:  Ernesto L Schiffrin; Mark L Lipman; Johannes F E Mann
Journal:  Circulation       Date:  2007-07-03       Impact factor: 29.690

10.  Clinical and Genetic Analysis of Multiple Endocrine Neoplasia Type 1-Related Primary Hyperparathyroidism in Chinese.

Authors:  Jing Kong; Ou Wang; Min Nie; Jie Shi; Yingying Hu; Yan Jiang; Mei Li; Weibo Xia; Xunwu Meng; Xiaoping Xing
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

View more
  2 in total

Review 1.  Clinical aspects of multiple endocrine neoplasia type 1.

Authors:  Abdallah Al-Salameh; Guillaume Cadiot; Alain Calender; Pierre Goudet; Philippe Chanson
Journal:  Nat Rev Endocrinol       Date:  2021-02-09       Impact factor: 43.330

Review 2.  Update on the clinical management of multiple endocrine neoplasia type 1.

Authors:  Carolina R C Pieterman; Gerlof D Valk
Journal:  Clin Endocrinol (Oxf)       Date:  2022-04-01       Impact factor: 3.523

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.